Efficacy, safety and cost-effectiveness of vonoprazan vs Proton Pump Inhibitors in reflux disorders and H. pylori eradication: A literature review

Gastroesophageal reflux disease (GERD) is one of the most prevalent conditions worldwide and is conventionally treated by proton pump inhibitor therapy. However, around 40% of people have reported some form of resistance to this therapy. Vonoprazan has recently been approved for the treatment of GER...

Descripción completa

Detalles Bibliográficos
Autores principales: Shehryar, Muhammad, Ahmad, Rana Uzair, Kareem, Hira Khalid, Khan, Laiba, Ashraf, Muhammad Fawad, Hassan, Ahtizaz, Saeed, Sabeena, Tareen, Haseeb Khan, Nazir, Dr Adnan, Ashraf, Muhammad Aizaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577871/
https://www.ncbi.nlm.nih.gov/pubmed/36268393
http://dx.doi.org/10.1016/j.amsu.2022.104760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577871/
https://www.ncbi.nlm.nih.gov/pubmed/36268393
http://dx.doi.org/10.1016/j.amsu.2022.104760

Ejemplares similares